In a retrospective case series, Mao et al3 reviewed 214 COVID-19 confirmed hospitalized patients in Wuhan, China, 74 of whom had neurological signs or symptoms. Comparing patients with severe and nonsevere COVID-19 infections as defined by international guidelines for community-acquired pneumonia, patients with severe infection were more likely to have CNS manifestations of disease. Specifically, impaired consciousness and acute stroke were more common in severe cases. There was a single case of epilepsy, in the severe group. Additionally, there was associated hypogeusia and hyposmia in 5.6% and 5.1% of patients, respectively, which showed no difference in occurrence between the severe and nonsevere groups. Muscle injury was reported in 10.7%. In a pediatric study, the International COVID-19 PICU Collaborative7 published a cross-sectional study of North American pediatric intensive care units describing the characteristics of 48 critically ill children positive for COVID-19. Two patients had an uncharacterized “neurological” presentation, and 3 patients had seizures as a comorbidity. The intensive care unit (ICU) mortality in this cohort was <5%, significantly lower than adult ICU mortality rates published in other comparable studies.